Pine Labs Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 7 Aug 2026 | Financial Technology (Fintech) | Market Cap: ₹17.1K Cr
Q3 was a record-breaking quarter with strong revenue and PAT growth. Q3 FY2026 was a record-breaking quarter with strong revenue and PAT growth, signaling robust business momentum.
From Pine Labs Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹157
Market Cap
₹17.1K Cr
P/E Ratio
131.8
How does Pine Labs Ltd rank in Financial Technology (Fintech)?
Compare Pine Labs Ltd against every Financial Technology (Fintech) company this quarter on revenue, margins and earnings-call signals.
Pine Labs Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹701 Cr, net profit ₹59 Cr.
Full financials →📊 Revenue & Sales Performance
- →Q3 was a record-breaking quarter with strong revenue and PAT growth.
- →Payment volumes continue to increase on Pine Labs' platforms, reflecting robust market demand.
- →The company expects to maintain a buoyant mood into Q4, anticipating similar strong performance.
- →Issuance business grew 42%, digital payments business grew 16%, contributing to overall 24% revenue growth year-over-year.
- →Value-added services (VAS) activating more merchants, with VAS volumes growing 41% year-on-year.
- →Continuous product innovation and geographic expansion are driving growth.
- →Over 120 new brands onboarded in Q3, expanding market share domestically and internationally.
- →The company emphasizes sustainable growth with operating leverage and cost management ensuring margin expansion.
- →AI-driven efficiencies support scalability without proportionate increase in engineering headcount.
- →Overall, Pine Labs expects ongoing strong growth in transactions, revenues, and geographic presence.
📈 Profitability & Margins
- →Q3 FY2026 was a record-breaking quarter with strong revenue and PAT growth, signaling robust business momentum.
- →Revenue grew 24% YoY to Rs.744 Crores; digital payments grew 16%, and issuance business grew 42%.
- →Contribution margin steady at ~76%, indicative of operating leverage and cost efficiencies.
- →Adjusted EBITDA margin expanded to 23%, reflecting improved operating scale; PAT stood at Rs.42 Crores despite one-time labor code reform cost.
- →Operating leverage expected to sustain: every additional Rs.100 contribution translating to Rs.50-57 adjusted EBITDA flow-through.
- →Headcount growth limited (~6%), with significant productivity gains via technology and AI, supporting margin expansion.
- →Depreciation and capex to remain range-bound with a continued shift to asset-light model, aiding profit growth.
- →Value-added services and new product innovation are key growth drivers, supporting long-term upward profit trajectory.
- →No forward EPS guidance provided explicitly, but improved margins and scale point to positive profit and earnings growth ahead.
🏗️ Capital Expenditure Plans
- →Depreciation and capex are expected to remain range-bound going forward.
- →As a tech platform, Pine Labs aims for an asset-light model by having devices directly bought by merchants and banks, reducing the need for heavy capex.
- →No structural decline in net capex is anticipated, but depreciation as a percentage of revenue is expected to reduce due to changes in business mix and refurbished terminals.
- →Investments continue in new products and geographies, with no intention of reducing team size despite efficiency gains from AI.
- →The company is focused on expanding its digital payments and issuance businesses, including international market expansion and fintech infrastructure, implying ongoing strategic investments.
- →Use of AI is increasing, with 21% of code written via AI to enhance product innovation and operational efficiency without significant additional hiring.
💰 Fundraising & Capital Structure
- →The transcript provided does not mention any current or planned fundraising activities through debt or equity.
- →Management focuses on strong operational performance, revenue growth, and profitability improvements.
- →There is emphasis on expanding business through organic growth, new products, and market expansion rather than external fundraising.
- →No direct references to equity issuance, debt raising, or capital markets activities were made in the Q&A or closing remarks.
- →For specific updates on fundraising plans, the management suggests reaching out to the investor relations desk or checking official company communications.
📋 Order Book & Pipeline
- →The transcript does not explicitly mention the current or expected orderbook/pending orders in numeric terms.
- →However, it emphasizes strong ongoing deal wins, including 120 new brands added in Q3 across offers, affordability, and prepaid services.
- →The company has secured significant contracts recently, such as with Wio Bank (a rapidly growing digital bank in the Middle East) and a Sri Lankan card issuing platform.
- →Revenue growth and transaction volumes are robust, indicating a healthy pipeline of transactions flowing from these deals.
- →Pine Labs operates on a transaction-based revenue model rather than upfront project fees, implying orderbook translates into continuous transaction volumes.
- →No specific pending order value or formal orderbook disclosure is provided in the provided pages.
Key Metrics
Frequently Asked Questions
What were Pine Labs Ltd Q3 FY26 results?
Q3 was a record-breaking quarter with strong revenue and PAT growth. Q3 FY2026 was a record-breaking quarter with strong revenue and PAT growth, signaling robust business momentum.
What is Pine Labs Ltd share price analysis?
Pine Labs Ltd currently shows a neutral. The stock trades at a P/E of 131.8 with a market cap of ₹17,056 Cr. Investors should review the full earnings analysis for detailed insights.
Is Pine Labs Ltd planning capital expenditure?
Depreciation and capex are expected to remain range-bound going forward.
Keep Pine Labs Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.